Evidence map›Paper›PMID 35626660›Full record

ArticleCells2022

The Impact of

Lenka Súkeníková, Viktor Černý, Jan Věcek, Petra Petrásková, Olga Novotná, Šimon Vobruba, Tereza Michalčíková, Jan Procházka, Libuše Kolářová, Ludmila Prokešová and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lenka SúkeníkováFirst Faculty of Medicine, Charles University and General University Hospital, 121 08 Prague, Czech Republic.
Viktor ČernýFirst Faculty of Medicine, Charles University and General University Hospital, 121 08 Prague, Czech Republic.ORCID 0000-0002-8319-7827
Jan VěcekFirst Faculty of Medicine, Charles University and General University Hospital, 121 08 Prague, Czech Republic.
Petra PetráskováFirst Faculty of Medicine, Charles University and General University Hospital, 121 08 Prague, Czech Republic.
Olga NovotnáFirst Faculty of Medicine, Charles University and General University Hospital, 121 08 Prague, Czech Republic.
Šimon VobrubaCzech Academy of Sciences, 142 20 Prague, Czech Republic.
Tereza MichalčíkováCzech Centre for Phenogenomics, Institute of Molecular Genetics, Czech Academy of Sciences, 252 50 Vestec, Czech Republic.ORCID 0000-0002-0172-2254
Jan ProcházkaCzech Centre for Phenogenomics, Institute of Molecular Genetics, Czech Academy of Sciences, 252 50 Vestec, Czech Republic.
Libuše KolářováFirst Faculty of Medicine, Charles University and General University Hospital, 121 08 Prague, Czech Republic.
Ludmila ProkešováFirst Faculty of Medicine, Charles University and General University Hospital, 121 08 Prague, Czech Republic.
Jiří HrdýFirst Faculty of Medicine, Charles University and General University Hospital, 121 08 Prague, Czech Republic.ORCID 0000-0003-0612-4509
Charles University · CZCzech Academy of Sciences · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early postnatal events are important for the development of the neonatal immune system. Harboring the pioneering microorganisms forming the microbiota of the neonatal gastrointestinal tract is important for priming the immune system, as well as inducing appropriate tolerance to the relatively innocuous environmental antigens and compounds of normal healthy microbiota. Early postnatal supplementation of suitable, safe probiotics could accelerate this process. In the current study, the immunomodulatory capacity of the probiotic strain of

Indexed as

MicrobiotaProbioticsDendritic CellsEscherichia coliHumansInfant, NewbornInterleukin-10Interleukin-10dendritic cellearly postnatal probiotic administrationE. coli O83:K24:H31IL-10indol amine 2,3 dioxygenaseluciferaseprobiotic

Identifiers

PMID35626660
PMCPMC9140140
OpenAlexW4280613341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.